Attached files
| file | filename |
|---|---|
| EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ALEXION PHARMACEUTICALS, INC. | alxnex31212312015.htm |
| EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - ALEXION PHARMACEUTICALS, INC. | alxnex31112312015.htm |
| EX-32.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 906 - ALEXION PHARMACEUTICALS, INC. | alxnex32112312015.htm |
| EX-21.1 - SUBSIDIARIES OF ALEXION PHARMACEUTICALS, INC. - ALEXION PHARMACEUTICALS, INC. | alxnex21112312015.htm |
| 10-K - FORM 10-K - ALEXION PHARMACEUTICALS, INC. | alxn10k12312015.htm |
| EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - ALEXION PHARMACEUTICALS, INC. | alxnex32212312015.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S‑3 (No. 333-206345) and Form S-8 (No. 333,205379, 333-204426, 333-146319, 333-139600, 333-123212 and 333-153612) of Alexion Pharmaceuticals, Inc. of our report dated February 8, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Hartford, Connecticut
February 8, 2016